<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-L0EK0QV6</identifier><date>2015</date><creator>Zabavnik, Valerija</creator><relation>documents/doc/L/URN_NBN_SI_doc-L0EK0QV6_001.pdf</relation><relation>documents/doc/L/URN_NBN_SI_doc-L0EK0QV6_001.txt</relation><format format_type="issue">1</format><format format_type="volume">66</format><format format_type="type">article</format><format format_type="extent">str. 42-48</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">281546240</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-L0EK0QV6</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">antiepileptiki</subject><subject language_type_id="eng">drug</subject><subject language_type_id="slv">interakcije med zdravili</subject><subject language_type_id="slv">zdravila</subject><title>Anti-epileptic drugs interactions</title><title>clinical case</title><title>Interakcije antiepileptičnih zdravil</title><title>klinični primer</title></Record>